Abcely is a biotechnology company developing a proprietary platform for orally active sIgA-based immunotherapy to treat mucosal cancers and chronic mucosal diseases
Abcely is a biotechnology company developing a proprietary platform for orally active sIgA-based immunotherapy to treat mucosal cancers and chronic mucosal diseases.